Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can stop taking Wegovy after losing weight — but trial evidence is clear that for most people, the weight returns if they do. Semaglutide works by continuously regulating the hormonal signals that drive appetite; once those signals are no longer being modified, hunger typically returns to pre-treatment levels within weeks to months. That is not a failure of willpower. It reflects the biology of a chronic condition. As a prescription-only medicine, any decision about stopping or continuing Wegovy should be made with your prescribing clinician, not based on how the scales look on a given morning.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clearest data on this question comes from the STEP 1 withdrawal phase, published alongside the main semaglutide 2.4mg results. After 68 weeks, participants who had lost on average around 15% of their body weight were taken off semaglutide. Within a year of stopping, they had regained roughly two-thirds of that lost weight. Diet and activity support continued throughout. The weight came back anyway. The full STEP 1 paper in the New England Journal of Medicine documents both the original loss and the regain trajectory, and it is worth reading if you want the numbers without a journalist's framing.
There is a misconception worth naming gently here: many people start Wegovy expecting it to reset something permanently, so that stopping becomes the goal. The evidence does not support that model. Semaglutide addresses a chronic biological condition, it does not cure it. That is not a reason to feel trapped, and our page on whether you can stop taking semaglutide walks through what the evidence actually says about that decision. It is simply useful to know before you make a plan.
If you are weighing up what Wegovy realistically achieves over a course of treatment, having an honest picture of what stopping typically means is part of the same conversation.
Semaglutide works by activating GLP-1 receptors involved in appetite regulation, satiety signals sent from the gut to the brain, and the rate at which the stomach empties. While you are taking it, hunger is genuinely blunted and fullness arrives more readily. When you stop, those effects stop. The receptors return to their baseline state. Hunger comes back, often strongly, and portion sizes that felt comfortable on treatment can start to feel inadequate.
This is not a side effect of stopping, it is simply the absence of the medicine's effect. The NHS medicines page for semaglutide notes that weight management medicines work best as part of an ongoing, supervised programme rather than a fixed course. That framing matters practically: if you are approaching Wegovy as a short-term fix with a planned end date, it is worth discussing that plan with your prescriber well in advance of stopping.
Questions about the right point to consider stopping Wegovy are ones our prescribers hear regularly, and there is no single correct answer, it depends on your starting point, how much you have lost, what your health goals are, and whether underlying conditions have improved.
If you are thinking about stopping, do not simply put the pen down and see what happens, talk to your prescriber first. There are a few different situations worth distinguishing. Some people stop because they have reached a weight that meaningfully reduces their health risks and feel they can sustain it. Others stop because of side effects, cost, or because the medicine is not working as hoped. And some stop unexpectedly because of supply issues or a change in circumstances. Each of those situations calls for a different conversation.
Practically, there is no evidence-based tapering protocol for stopping Wegovy the way there is for some other medicines. Stopping at any point in the dose schedule is not physically dangerous. If you want a fuller picture of whether you can stop taking Wegovy and what to expect when you do, that is covered in detail separately. But the sudden return of appetite that many people notice can be disorienting, especially if they have been on treatment for a year or more and have genuinely forgotten what unrestricted hunger felt like.
If you have already stopped and are now watching the weight return, that is also a common and documented experience. It does not mean treatment failed. It may mean treatment needs to continue. Guidance on how to approach stopping Wegovy thoughtfully is available if you want to think through the steps. And if you are reconsidering whether to restart or switch (including what how long Wegovy takes to produce results should look like the second time around) that is exactly the kind of question a prescriber can help you work through.
Wegovy is a prescription-only medicine. If you are thinking about starting, restarting, or reviewing your treatment, a free clinical consultation is the right first step. Our prescribers review every consultation the same day it is submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.